Scrivo, Rossana, et al. “Secukinumab Treatment in Patients With Spondyloarthritis and Concomitant Demyelinating Disease: Rationale of IL-17 Inhibition and Clinical Outcome”. Archives of Clinical and Medical Case Reports, vol. 6, no. 5, Oct. 2022, pp. 660-8, https://fortunejournals.org/ojs/index.php/acmcr/article/view/22670.